Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

692 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Baruch J, Denayer S, Seyler L, Domegan L, Launay O, Machado A, Burgui C, Vaikutyte R, Niessen FA, Loghin II, Husa P, Aouali N, Panagiotakopoulos G, Tolksdorf K, Horváth JK, Howard J, Pozo F, Gallardo V, Nonković D, Džiugytė A, Bossuyt N, Demuyser T, Duffy R, Luong Nguyen LB, Kislaya I, Martínez-Baz I, Gefenaite G, Knol MJ, Popescu C, Součková L, Simon M, Michelaki S, Reiche J, Ferenczi A, Delgado-Sanz C, Lovrić Makarić Z, Cauchi JP, Barbezange C, Van Nedervelde E, O'Donnell J, Durier C, Guiomar R, Castilla J, Jonikaite I, Bruijning-Verhagen PC, Lazar M, Demlová R, Wirtz G, Amerali M, Dürrwald R, Kunstár MP, Kissling E, Bacci S, Valenciano M; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above). Rose AM, et al. Among authors: castilla j. Euro Surveill. 2023 Nov;28(47):2300187. doi: 10.2807/1560-7917.ES.2023.28.47.2300187. Euro Surveill. 2023. PMID: 37997665 Free PMC article.
Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, Alvarez N, Arriazu M, Elía F, Salcedo E, Barricarte A; Primary Health Care Sentinel Network of Navarre. Castilla J, et al. Vaccine. 2011 Aug 11;29(35):5919-24. doi: 10.1016/j.vaccine.2011.06.063. Epub 2011 Jun 30. Vaccine. 2011. PMID: 21723358
Use of medical care during pandemic (H1N1) 2009, Navarre, Spain.
Burgui R, Martínez-Baz I, Guevara M, Carlos S, Castilla J. Burgui R, et al. Among authors: castilla j. Emerg Infect Dis. 2011 Aug;17(8):1463-6. doi: 10.3201/eid1708.101817. Emerg Infect Dis. 2011. PMID: 21801624 Free PMC article.
[Effect of the time between symptom onset, swabbing and testing on the detection of influenza virus].
Martínez-Baz I, Reina G, Martínez-Artola V, Fernández-Alonso M, Salcedo E, Mazón A, Castilla J; Red de Médicos Centinela de Gripe de Navarra. Martínez-Baz I, et al. Among authors: castilla j. Enferm Infecc Microbiol Clin. 2012 Jan;30(1):11-4. doi: 10.1016/j.eimc.2011.06.005. Epub 2011 Sep 7. Enferm Infecc Microbiol Clin. 2012. PMID: 21903301 Spanish.
Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.
Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, Vanrell JM, Rodriguez C, Vega T, Martinez A, Torner N, Ramos JM, Serrano MC, Castilla J, Cenoz MG, Altzibar JM, Arteagoitia JM, Quiñones C, Perucha M, Larrauri A. Savulescu C, et al. Among authors: castilla j. BMC Public Health. 2011 Nov 30;11:899. doi: 10.1186/1471-2458-11-899. BMC Public Health. 2011. PMID: 22129083 Free PMC article.
692 results